Clinical trial
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell…
NCT00006374 · Case Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00006374 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | An Open-Label, Multicenter, Randomized, Phase II Study of Topotecan/Paclitaxel vs Etoposide/Cisplatin as First-Line Therapy for Patients With Extensive Disease Small Cell Lung Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cisplatin, etoposide, paclitaxel, topotecan hydrochloride |
| Enrollment | 0 |
| Start date | Oct 1, 1999 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Jun 9, 2004 |
| Last update posted | Jan 15, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: